I think it's time we put this Hartindo talk to bed. There are no Hartindo rights any more where MEVT is concerned.
That MGON 8K states that Newstar is supporting and supplying them with Hartindo product. Since MEVT started touting this new and better competing product and publically stating its superiority to Hartindo my guess is they have a snowballs chance of ever dealing with Newstar directly.
The way MEVT handled the whole Hartindo thing has been a cluster*** from the get go. I think we can all agree to that.
MEVT then sold rights they don't have to EPRO (who I need not remind everyone is run by the same mgmnt at MEVT).
So, someone please explain to me now what MEVT has (since there is still no evidence of this 'new' inhibitor) and more importantly explain why we should be excited about EPRO since now, without Hartindo, they have absolutely NOTHING!
Furthermore, how is that $5M note, now in the form of EPRO shares (that are being 'investigated' for use as a dividend for us long suffering mevt holders) going to pass muster when the SEC sees that no product rights were actually part of the transaction?
Sorry, but it's very confusing to figure out what MEVT and EPRO actually will be doing to create revenue.
As cisco stated, any previous agreements, or for a better term where EPRO is concerned, "arrangements", that have to do with Hartindo are out the door. Gone. Extinct.
Until MEVT unveils this new mystery product I am still inclined to think we need those other parties back in the game if we are going to see any $. As I stated long ago, that is not likely to happen with the current mgmnt.
Just my humble opinion.
AI
